1,127
Views
29
CrossRef citations to date
0
Altmetric
Research Article

Metabolic Activities of the Gut Microflora in Relation to Cancer

Pages 179-185 | Published online: 11 Jul 2009

References

  • Cummings JH, Macfarlane GT. Role of intestinal bacteria in nutrient metabolism. Clin Nutr 1997; 16: 3–11.
  • Nanno M, Morotomi H, Takayama H, Kuroshima T, Tanaka R, Mutai M. Mutagenic activity of biliary metabo-lites of benzoapyrene by 13-glucuronidase positive bacteria in human faeces. J Med Microbiol 1986; 22: 351–5.
  • Takada H, Hirook T, Hiramatasu Y, Yamamato M. A model for activation of dietary glycosides to mutagens by intestinal flora. Cancer Res 1982; 42: 331–4.
  • Turesky RJ, Markovic J, Bracco-Hammer I, Fay LB. The effect of dose an cytochrome P450 induction on the metabolism and disposition of the food borne carcinogen 2-amino-3,8-dimethylimidazo[4,5Thuinoxaline (MeIQx) in the rat. Carcinogenesis 1991; 12: 1847–55.
  • Roberton AM, Lee SP, Lindop R, Stanley RA, Thompson L, Tasman-Jones C. Biliary control of 13-glucuronidase activity in the luminal contents of rat ileum, caecum and rectum. Cancer Res 1982; 42: 5165–6.
  • Reddy BS, Weisburger JH, Narisawa T, Wynder EL. Colon carcinogenesis in germfree rats with 1,2-dimethylhydrazine and N-methyl-N-nitro-N-nitrosoguanidine. Cancer Res 1974; 74: 2368–72.
  • Brown JP. Reduction of polymeric azo and nitro dyes by intestinal bacteria. Appl Environ Microbiol 1981; 41: 1283–6.
  • Rowland IR, Manett AK, Wise A. The effect of diet on the mammalian gut flora and its metabolic activities. CRC Crit Rev Toxicol 1985; 16: 31–103.
  • Goldin BR. The metabolism of the intestinal microflora and its relationship to dietary fat, colon and breast cancer. Prog Clin Biol Res 1986; 222: 655–85.
  • Mirsalis JC, Hamm TE, Sherrill JM, Butterworth BE. Role of gut flora in genotoxicity of dinitrotoluene. Nature 1982; 295: 322–3.
  • Allison C, MacFarlane GT. Effect of nitrate on methane production and fermentation by slurries of human faecal bacteria. J Gen Microbiol 1988; 134: 1397–405.
  • Leach SA, Cook AR, Challis BC, Hill MJ, Thompson MH. Bacterially mediated N-nitrosation reactions and endogenous formation of N-nitroso compounds. In: Bartsch H, O'Neill IK, Schulte-Herman R, eds. Relevance of N-nitrosocom-pounds to human cancer: exposures and mechanisms. Lyon: IARC Scientific Publications, 1987.
  • Calmels S, Ohshima H, Vmcent P, Gounot AM, Bartsch H. Screening of microorganisms for nitrosation catalysis at pH7 and kinetics studies on nitrosamine formation from secondary amines by E. colt strains. Carcinogenesis 1985; 6: 911–5.
  • Calmels S, Ohshima H, Bartsch H. Nitrosamine formation by denitrifying and non-denitrifying bacteria: implication of ni-trite reductase and nitrate reductase in nitrosation catalysis. J Gen Microbiol 1988; 134: 221–6.
  • Calmels S, Ohshima H, Henry Y, Bartsch H. Characterization of bacterial cytochrome cdfnitrite reductase as one enzyme responsible for catalysis of secondary amines. Carcinogenesis 1996; 17: 533–6.
  • Gross GA, Turesky RJ, Fay LB, Stillwell WG, Skipper PL, Tannenbaum SR. Heterocyclic aromatic amine formation in grilled bacon, beef and fish and in grill scrapings. Carcinogen-esis 1993; 14: 2313–8.
  • Layton DW, Bogen KT, Knize MG, et al. Cancer risk of heterocyclic amines in cooked foods: an analysis and implica-tions for research. Carcinogenesis 1995; 16: 39–52.
  • Pence BC, Landers M, Dunn DM, Shen CL, Miller MF. Feeding of a well cooked beef diet containing a high hetero-cyclic amine content enhances colon and stomach carcinogen-esis in 1, 2-dimethylhydrazinetreatekl rats. Nutr Cancer 1998; 30: 220–6.
  • Ohgaki H, Takayama S, Sugimura T. Carcinogenicities of heterocyclic amines. Mut Res 1991; 259: 399–411.
  • Carman RJ, Van Tassell RL, Kingston DGI, Bashir M, Wilkins TD. Conversion of IQ, a dietary pyrolysis carcinogen, to a direct-acting mutagen by normal intestinal bacteria of human. Mut Res 1988; 206: 335–42.
  • Rumney CJ, Rowland IR, O'Neill IK. Conversion of IQ to 7-0HIQ by gut microflora. Nutr Cancer 1993; 19: 67–76.
  • Saito Y, Takano T, Rowland IR. Effects of soybean oligosac-charides on the human gut microflora in in vitro culture. Microb Ecol Health Dis 1992; 5: 105–10.
  • Rowland IR, Tanaka R. The effects of transgalactosylatekl oligosaccharides on gut flora metabolism in rats associated with a human faecal microflora. J Appl Bacteriol 1993; 74: 667–74.
  • Kikuchi H, Andrieux C, Riottot M, et al. Effect of two transgalactosylated oligosaccharide intake in rats associated with human faecal microflora on bacterial glycolytic activity, end products of fermentation and bacterial steroid transfor-mation. J Appl Bacteriol 1996; 80: 439–46.
  • Terada A, Hara H, Kataoka M, Mitsuoka T. Effect of lactulose on the composition and metabolic activity of the human faecal flora. Microb Ecol Health Dis 1992; 5: 43–50.
  • Buddington RK, Williams CH, Chen S-C, Witherly SA. Dietary supplement of Neosugar alters the faecal flora and decreases activities of some reductive enzymes in human subjects. Am J Clin Nutr 1996; 63: 709–16.
  • Reddy BS. Prevention of colon cancer by pre- and probiotics: evidence from laboratory studies. Br J Nutr 1998; 80: S217–23.
  • Rowland IR, Rumney CJ, Coutts JT, Lievense LC. Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen induced aberrant crypt foci in rats. Carcinogenesis 1998; 19: 281–5.
  • MacFarlane GT, Cummings JH. The colonic flora, fermenta-tion and large bowel digestive function. In: Phillips SF, Pemberton JH, Shorter RG, eds. The large intestine: physiol-ogy, pathophysiology and disease. New York: Raven Press Ltd., 1991.
  • Chacko A, Cummings JH. Nitrogen losses from the human small bowel: obligatory losses and the effect on the physical for of food. Gut 1988; 29: 809–15.
  • MacFarlane GT, Cummings JH, Allison C. Protein degrada-tion by human intestinal bacteria. J Gen Microbiol 1986; 132: 1647–56.
  • Gibson GR An overview of the composition and activities of the human colonic microbiota. In: Malkki Y, Cummings JH, eds. Dietary fibre and fermentation in the colon. Finland: Office for Official Publications of the European Communities, 1996: 9–11.
  • Cummings JH, Hill MJ, Bone ES, Branch WJ, Jenkins DJA. The effect of meat protein and dietary fibre on colonic function and metabolism. II. Bacterial metabolites in faeces and urine. Am J Clin Nutr 1979; 32: 2094–101.
  • Silvester KR, Bingham SA, Pollock JRA, Cummings JH, O'Neill IK. Effect of meat and resistant starch on faecal excretion of apparent total N-nitroso compounds and ammo-nia from the human large bowel. Nutr Cancer 1997; 29: 13–23.
  • Geypens B, Claus D, Evenepoel P, et al. Influence of dietary protein supplements on the formation of bacterial metabolites in the colon. Gut 1997; 41: 70–6.
  • Visek WK. Diet and cell growth modulation by ammonia. Am J Clin Nutr 1978; 31: S216–20.
  • Elsden SR, Hilton MG, Walker JM. The end products of the metabolism of aromatic amino acids by clostridia. Arch Mi-crobiol 1976; 107: 283–8.
  • Chung KT, Anderson GM, Fulk GE Formation of indole acetic acid by intestinal anaerobes. J Bacteriol 1975; 124: 573–5.
  • Botsford JL, Desmoss RD. Escherichia Colt tryptophanase in the enteric environment. J Bacteriol 1972; 109: 74–80.
  • Aragozzini F, Ferrari A, Pacini N, Saulandris R. Indole-3-lac-tic acid as a tryptophan metabolite produced by Bifidobac-terium spp. Appl Environ Mircobiol 1979; 38: 544–6.
  • Yokoyama MT, Carlson JR Dissimilation of tryptophan and related indolic compounds by ruminal microorganism in vitro. Appl Microbiol 1981; 27: 540–8.
  • Kikugawa K, Kato T. Formation of a mutagenic diazo-quinone by interaction of phenol with nitrite. Fd Chem Toxicol 1986; 26: 209–14.
  • Ohshima H, Bartsch H. Quantitative estimation of endoge-nous nitrosation in humans by monitoring N-nitroso proline excreted in the urine. Cancer Res 1981; 41: 3658–62.
  • Massey RC, Key PE, Mallett AK, Rowland IR. An investiga-tion of the endogenous formation of apparent total N-nitroso compounds in conventional microflora and germ-free rats. Fd Chem Toxicol 1988; 26: 595–600.
  • Rowland IR, Granli T, Bockman OC, Key PE, Massey RC. Endogenous N-nitrosation in man assessed by measurement of apparent total N-nitroso compound in faeces. Carcinogen-esis 1991; 12: 1395–401.
  • Bingham SA, Pignatelli P, Pollock JRA, et al. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis 1996; 17: 515–23.
  • Parodi PW. The role of intestinal bacteria in the causation and prevention of cancer: modulation by diet and probiotics. Austr J Dairy Technol 1999; 54: 103–21.
  • Hirai N, Kingston DGI, van Tassell RL, Wilkins TD. Struc-ture elucidation of a potent mutagen from human feces. J Am Chem Soc 1982; 104: 6149–50.
  • Schiffman MH, van Tussell RL, Robinson A, et al. Case control study of colorectal cancer and fecapentaene excretion. Cancer Res 1989; 49: 1322–6.
  • Plummer SM, Grafstom RC, Yang LL, et al. Fecapentaene-12 causes DNA damage and mutations in human cells. Car-cinogenesis 1986; 7: 1607–9.
  • Hinzman MJ, Novotny C, Ullah A, Shamsuddin AM. Fecal mutagen fecapentaene-12 damages mammalian colon epithe-lial DNA. Carcinogenesis 1987; 8: 1475.
  • Ward JM, Anjo T, Ohannesian L, et al. Inactivity of fecapen-taene-12 as a rodent carcinogen or tumor initiator. Cancer Lett 1988; 42: 49.
  • Weisburger JH, Jones RC, Wang CX, et al. Carcinogenicity tests of fecapentaene-12 in mice and rats. Cancer Lett 1990; 49: 89.
  • Shamsuddin AM, Ullah A, Baten A, Hale E. Stability of fecapentaene-12 and its carcinogenicity in F344 rats. Carcino-genesis 1991; 12: 601–7.
  • Zarkovic M, Qin X, Nakatsuru Y, et al. Tumor promotion by fecapentaene-12 in a rat colon carcinogenesis model. Carcino-genesis 1993; 14: 1261.
  • De Kok TMCM, van Faasen A, ten Hoor F, Kleinjans JCS. Fecapentaene excretion and fecal mutagenicity in relation to nutrient intake and fecal parameters in humans on omnivo-rous and vegetarian diets. Cancer Lett 1992; 62: 11.
  • Nagengest FM, Grubben MJAL, van Munster IP. Role of bile acids in colorectal carcinogenesis. Eur J Cancer 1995; 31A: 1067–70.
  • Radley S, Pongracz J, Lord J, Neoptolemos JP. Bile acids and colorectal cancer. Cancer Top 1996; 10: 1–7.
  • Venturi M, Hambly RJ, Glinghammar B, Rafter JJ, Rowland IR. Genotoxic activity in human faecal water and the role of bile acids: a study using the alkaline comet assay. Carcinogen-esis 1997; 18: 2353–9.
  • Nagengest FM. Bile acids and colonic carcinogenesis. Scand J Gastroenterol 1988; 103: 1783–9.
  • Franke AA, Custer LJ. Diadzein and genistein concentrations in human milk after soy consumption. Clin Chem 1996; 42: 955–64.
  • Setchell KDR, Aldercreutz H. Mammalian lignans and phy-toestrogens: metabolism and biological roles in health and disease. In: Rowland IR, ed. The role of gut microflora in toxicity and cancer. New York: Academic Press, 1988: 315–45.
  • Rowland I, Wiseman H, Sanders T, Aldercreutz H, Bowey E. Metabolism of oestrogens and phytoestrogens: role of the gut microflora. Biochem Soc Transactions 1999; 27: 304–8.
  • Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. Pyto-oestrogens: where are we now? Br J Cancer 1998; 79: 1–15.
  • Aldercreutz H. Dietary lignans and isoflavonoid phytoestro-gens and cancer. Kliinisk Laboratorie 1993; 2A 4–12.
  • Serraino M, Thompson LU. Flaxseed supplementation and early markers of colon carcinogenesis. Cancer Lett 1992; 63: 159.
  • Steele YE, Pereira M, Sigman C, Kelloff G. Cancer chemo-prevention agent development strategies for genistein. J Nutr 1995; 125: S713–6.
  • Jenab M, Thompson LU. The influence of flaxseed and lignans on colon carcinogenesis and fl-glucuronidase activity. Carcinogenesis 1996; 17: 1343–8.
  • Kuo SM. Antiproliferative potency of distinct dietary flavonoids on human colon cancer cell lines. Cancer Lett 1996; 110: 41–8.
  • Tetsuka T, Srivastava SK, Morrison AR. Tyrosine kinase inhibitors, genistein and herbimycin A, do not block inter-leukin-113 induced activation of NF-KB in rat mesangial cells. Biochem Biophys Res Comms 1996; 218: 808–12.
  • Clarkson TW. General principles underlying the toxic action of metals. In: Friburg L, Nordbury GF, Vouk VB, eds. Handbook on Toxicology of Metals. Amsterdam: Elsevier, 1979: 99–117.
  • Rowland IR. Interaction of the gut flora with metal com-pounds. In: Hill MJ, ed. Role of gut bacteria in human toxicology and pharmacology. London: Taylor & Francis, 1995: 197–211.
  • Morotomi M, Mutai M. In vitro binding of potent mutagenic pyrolyzates to intestinal bacteria. J Natl Cancer Inst 1986; 77: 195–201.
  • Orrhage K, Sillerstrom E, Gustafsson JA, et al. Binding of mutagenic heterocyclic amines by intestinal and lactic acid bacteria. Mut Res 1994; 311: 239–48.
  • Bolognani F, Rumney CJ, Rowland IR. Influence of carcino-gen binding by lactic acid producing bacteria on tissue distri-bution and in vivo mutagenicity of dietary carcinogens. Fd Chem Toxicol 1997; 6: 535–45.
  • Willett WC. Diet, nutrition and avoidable cancer. Environ Health Perspectives 1995; 103: 165–70.